Zaloguj się

Gotowe bibliografie tematyczne / Acute exacerbation of interstitial lung diseases

Spis treści

Artykuły w czasopismach

Gotowa bibliografia na temat „Acute exacerbation of interstitial lung diseases”

Autor: Grafiati

Data publikacji: 21 września 2024

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Acute exacerbation of interstitial lung diseases”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Artykuły w czasopismach na temat "Acute exacerbation of interstitial lung diseases"

1

Aritonang, Rachel S., Fanny Fachrucha, Mia Elhidsi, and Ginanjar Arum Desianti. "Oxygen Therapy in Exacerbation of Interstitial Lung Disease." Respiratory Science 4, no. 3 (2024): 221–31. http://dx.doi.org/10.36497/respirsci.v4i3.129.

Pełny tekst źródła

Streszczenie:

Interstitial lung diseases (ILD) are a group of diseases that involve damage in the interstitial tissue, causing diffusion disorders which ultimately lead to hypoxemia. One of the conditions that aggravate hypoxemia in ILD patients is acute exacerbation. Acute exacerbation is a condition of deterioration of ILD that can occur in less than 1 month. During an acute exacerbation, there will be a worsening of the HRCT pattern with increased ground glass opacities and a worsening of the clinical picture including hypoxemia. Acute exacerbations are closely related to increased mortality rates. Oxyge

Style APA, Harvard, Vancouver, ISO itp.

2

Kolb, Martin, Benjamin Bondue, Alberto Pesci, et al. "Acute exacerbations of progressive-fibrosing interstitial lung diseases." European Respiratory Review 27, no. 150 (2018): 180071. http://dx.doi.org/10.1183/16000617.0071-2018.

Pełny tekst źródła

Streszczenie:

Acute exacerbation of interstitial lung disease (ILD) is associated with a poor prognosis and high mortality. Numerous studies have documented acute exacerbation in idiopathic pulmonary fibrosis (IPF), but less is known about these events in other ILDs that may present a progressive-fibrosing phenotype. We propose defining acute exacerbation as an acute, clinically significant respiratory deterioration, typically less than 1 month in duration, together with computerised tomography imaging showing new bilateral glass opacity and/or consolidation superimposed on a background pattern consistent w

Style APA, Harvard, Vancouver, ISO itp.

3

Abo Elwafa, GihanS, NaglaaB Ahmed, AmanyA Abou Zeid, and MaiA Abo Elhasab. "Noninvasive ventilation in acute exacerbation of interstitial lung diseases." Egyptian Journal of Chest Diseases and Tuberculosis 72, no. 1 (2023): 99. http://dx.doi.org/10.4103/ecdt.ecdt_40_22.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

4

Drakopanagiotakis, Fotios, Philipp Markart, and Paschalis Steiropoulos. "Acute Exacerbations of Interstitial Lung Diseases: Focus on Biomarkers." International Journal of Molecular Sciences 24, no. 12 (2023): 10196. http://dx.doi.org/10.3390/ijms241210196.

Pełny tekst źródła

Streszczenie:

Interstitial lung diseases (ILDs) are a large group of pulmonary disorders characterized histologically by the cardinal involvement of the pulmonary interstitium. The prototype of ILDs is idiopathic pulmonary fibrosis (IPF), an incurable disease characterized by progressive distortion and loss of normal lung architecture through unchecked collagen deposition. Acute exacerbations are dramatic events during the clinical course of ILDs, associated with high morbidity and mortality. Infections, microaspiration, and advanced lung disease might be involved in the pathogenesis of acute exacerbations.

Style APA, Harvard, Vancouver, ISO itp.

5

Drakopanagiotakis, Fotios, Ekaterina Krauss, Ira Michailidou, et al. "Lung Cancer and Interstitial Lung Diseases." Cancers 16, no. 16 (2024): 2837. http://dx.doi.org/10.3390/cancers16162837.

Pełny tekst źródła

Streszczenie:

Lung cancer continues to be one of the leading causes of cancer-related death worldwide. There is evidence of a complex interplay between lung cancer and interstitial lung disease (ILD), affecting disease progression, management strategies, and patient outcomes. Both conditions develop as the result of common risk factors such as smoking, environmental exposures, and genetic predispositions. The presence of ILD poses diagnostic and therapeutic challenges in lung cancer management, including difficulties in interpreting radiological findings and increased susceptibility to treatment-related tox

Style APA, Harvard, Vancouver, ISO itp.

6

Matsunashi, Atsushi, Kazuma Nagata, Takeshi Morimoto, and Keisuke Tomii. "Mechanical ventilation for acute exacerbation of fibrosing interstitial lung diseases." Respiratory Investigation 61, no. 3 (2023): 306–13. http://dx.doi.org/10.1016/j.resinv.2023.01.008.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

7

Papanikolaou, Ilias C., Fotios Drakopanagiotakis, and Vlasis S. Polychronopoulos. "Acute exacerbations of interstitial lung diseases." Current Opinion in Pulmonary Medicine 16, no. 5 (2010): 480–86. http://dx.doi.org/10.1097/mcp.0b013e32833ae49d.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

8

Akulkina, L. A., M. Yu Brovko, A. A. Schepalina, et al. "A case of severe COVID-19 in a patient with progressive fibrosing interstitial lung disease." PULMONOLOGIYA 32, no. 5 (2022): 763–69. http://dx.doi.org/10.18093/0869-0189-2022-32-5-763-769.

Pełny tekst źródła

Streszczenie:

Interstitial lung diseases (ILDs) is a wide group of diffuse parenchymal lung diseases that can lead to interstitial pulmonary fibrosis. Clinical course of all ILDs, in particular with chronic fibrosing phenotype, can be complicated by an acute exacerbation caused by infection. Today, data about clinical course of COVID-19 in patients with progressive interstitial lung diseases is limited. In this case we described the course of COVID-19 infection in a patient with an interstitial pneumonia with autoimmune features (IPAF) and a progressive pulmonary fibrosis (PPF). We also discussed the typica

Style APA, Harvard, Vancouver, ISO itp.

9

Magdy, Mohammed, Zainab Saaed, Emad Abd El-Aleem, and Madyan Mahmoud. "Clinical and radiological signs of acute exacerbation of interstitial lung diseases." Minia Journal of Medical Research 30, no. 3 (2019): 116–19. http://dx.doi.org/10.21608/mjmr.2022.221906.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

10

Ito, Yoko, Gen Tazaki, Yusuke Kondo, Genki Takahashi, and Fumio Sakamaki. "Therapeutic effect of nintedanib on acute exacerbation of interstitial lung diseases." Respiratory Medicine Case Reports 26 (2019): 317–20. http://dx.doi.org/10.1016/j.rmcr.2019.02.021.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

Więcej źródeł

Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!